These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29561467)

  • 21. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease.
    Rodrigues IK; Andrigueti M; de Oliveira Gil ID; de Lucca Schiavon L; de Andrade KR; Pereira IA; de Castro GR; Zimmermann AF; Saporiti LN; Bazzo ML; Neves FS
    Rheumatol Int; 2015 Feb; 35(2):359-66. PubMed ID: 25119827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
    Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
    Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis.
    Andretta MA; Vieira TD; Nishiara R; Skare TL
    Rheumatol Int; 2012 Feb; 32(2):551-4. PubMed ID: 21305298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease.
    Jansen A; Mandić AD; Bennek E; Frehn L; Verdier J; Tebrügge I; Lutz H; Streetz K; Trautwein C; Sellge G
    Scand J Gastroenterol; 2016 Dec; 51(12):1453-1461. PubMed ID: 27455092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.
    Olofsson T; Lindqvist E; Mogard E; Andréasson K; Marsal J; Geijer M; Kristensen LE; Wallman JK
    Rheumatology (Oxford); 2019 Jul; 58(7):1176-1187. PubMed ID: 30649509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Saccharomyces cerevisiae antibodies in Behçet's disease--a familial study.
    Monselise A; Weinberger A; Monselise Y; Fraser A; Sulkes J; Krause I
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S87-90. PubMed ID: 17067434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis.
    Sakly W; Jeddi M; Ghedira I
    Dig Dis Sci; 2008 Jul; 53(7):1983-7. PubMed ID: 18049897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
    Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
    Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
    Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
    Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Saccharomyces cerevisiae Antibodies as a Prognostic Biomarker in Children With Crohn Disease.
    Chandrakumar A; Georgy M; Agarwal P; 't Jong GW; El-Matary W
    J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):82-87. PubMed ID: 30789863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.
    Müller S; Schaffer T; Schoepfer AM; Hilty A; Bodmer T; Seibold F
    World J Gastroenterol; 2008 Jun; 14(23):3650-61. PubMed ID: 18595132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midkine in vitamin D deficiency and its association with anti-Saccharomyces cerevisiae antibodies.
    Serinkan Cinemre FB; Cinemre H; Karacaer C; Aydemir B; Nalbant A; Kaya T; Tamer A
    Inflamm Res; 2016 Feb; 65(2):143-50. PubMed ID: 26566633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
    Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
    Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease].
    Le Goff C; Chapelle JP; Lutteri L
    Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?
    Harrer M; Reinisch W; Dejaco C; Kratzer V; Gmeiner M; Miehsler W; Norman GL; Gangl A; Vogelsang H
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1281-5. PubMed ID: 14624150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet's disease.
    Krause I; Monselise Y; Milo G; Weinberger A
    Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S21-4. PubMed ID: 12371630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.